Genotoxicity Of Amorphous Silica Nanoparticles: Status And Prospects
Abstract
Amorphous silica nanoparticles (SNPs) are widely used in biomedical applications and consumer products. Little is known, however, about their genotoxicity and potential to induce gene expression regulation. Despite recent efforts to study the underlying mechanisms of genotoxicity of SNPs, inconsistent results create a challenge. A variety of factors determine particle–cell interactions and underlying mechanisms. Further, high-throughput studies are required to carefully assess the impact of silica nanoparticle physicochemical properties on induction of genotoxic response in different cell lines and animal models. In this article, we review the strategies available for evaluation of genotoxicity of nanoparticles (NPs), survey current status of silica nanoparticle gene alteration and genotoxicity, discuss particle-mediated inflammation as a contributing factor to genotoxicity, identify existing gaps and suggest future directions for this research.
Recommended Citation
M. Yazdimamaghani et al., "Genotoxicity Of Amorphous Silica Nanoparticles: Status And Prospects," Nanomedicine Nanotechnology Biology and Medicine, vol. 16, pp. 106 - 125, Elsevier, Feb 2019.
The definitive version is available at https://doi.org/10.1016/j.nano.2018.11.013
Department(s)
Chemical and Biochemical Engineering
Keywords and Phrases
Gene expression profile; Genotoxicity; Inflammation; Silica nanoparticles; Structure–activity relationship
International Standard Serial Number (ISSN)
1549-9642; 1549-9634
Document Type
Article - Journal
Document Version
Citation
File Type
text
Language(s)
English
Rights
© 2025 Elsevier, All rights reserved.
Publication Date
01 Feb 2019
PubMed ID
30529789

Comments
National Institute of Environmental Health Sciences, Grant R01ES024681